Term
|
Definition
- Left Main Coronary
- Right Coronary
- Circumflex
- Left Anterior Descending
|
|
|
Term
Ischemic Heart Disease is divided into two broad categories: |
|
Definition
- Chronic Coronary Artery Disease
-Stable Angina
2. Acute Coronary Syndromes
-Unstable Angina
-Non-ST Elevation Myocardial Infarction
-ST Elevation Myocardial Infarction |
|
|
Term
Pathophysiology of Unstable Angina |
|
Definition
- Plaque that has formed ruptures
- Platelet aggregation
- Thrombus formation
- Unopposed vasoconstriction
|
|
|
Term
Pathophysiology of Stable Angina |
|
Definition
- Lumen narrowed by atherosclerotic plaque
- Inappropriate vasoconstriction (caused by endothelial damage)
|
|
|
Term
Pathophysiology of Variant Angina |
|
Definition
- No overt plaques
- Intense vasospasm --> results in ischemia
|
|
|
Term
Depending on the anatomic site of the plaque rupture (in Unstable Angina), this process can lead to: |
|
Definition
- Non-Q wave (non-ST elevation) Myocardial Infarction
OR
2. Q wave (ST elevation) Myocardial Infarction |
|
|
Term
Chronic Coronary Artery Disease (Stable Angina)
Treatment Goal: |
|
Definition
Restore the balance between myocardial oxygen supply and myocardial oxygen demand |
|
|
Term
If myocardial O2 demand exceeds O2 supply: |
|
Definition
an ischemic episode results |
|
|
Term
Amyl Nitrite: Classification |
|
Definition
Vasodilator (organic nitrite) |
|
|
Term
Isosorbide Nitrate: Classification |
|
Definition
Vasodilator (organic nitrate) |
|
|
Term
Nitroglycerin: Classification |
|
Definition
Vasodilator (organic nitrate) |
|
|
Term
|
Definition
|
|
Term
Metoprolol: Classification |
|
Definition
|
|
Term
|
Definition
Non-Selective Beta Blocker |
|
|
Term
Propranolol: Classification |
|
Definition
Non-Selective Beta Blocker |
|
|
Term
Amlodipine: Classification |
|
Definition
|
|
Term
Nifedipine: Classification |
|
Definition
Rapid Release DHP Ca2+ Channel Blocker |
|
|
Term
Diltiazem: Classification |
|
Definition
Non-DHP Ca2+ Channel Blocker |
|
|
Term
Verapamil: Classification |
|
Definition
Non-DHP Ca2+ Channel Blocker |
|
|
Term
Ranolazine: Classification |
|
Definition
Fatty Acid Oxidation Inhibitor |
|
|
Term
Organic Nitrites and Nitrates: MOA |
|
Definition
- Dilation of venous capacitance vessels: results in reduced venous return, lower ventricular filling pressure (preload), decreases ventricular wall tension, reduces myocardial O2 demand
- Aterial dilation: results in reduced resistance to ventricular emptying (afterload), decrease cardiac work, reduced myocardial O2 demand
- Blood flow through collateral vessels improved: results in increased blood supply to ischemic areas of myocardium
|
|
|
Term
Organic Nitrites and Nitrates: Adverse Effects |
|
Definition
Due to excessive vasodilation:
- headache
- hypotension
- dizziness
- reflex tachycardia
|
|
|
Term
Organic Nitrites and Nitrates: Drug Interactions |
|
Definition
- PDE 5 Inhibitors: sildenafil (viagra)
-in the presence of PDE5 inhibitor, nitrates cause profound increases in cGMP and can cause dramatic reduction in blood pressure |
|
|
Term
Organic Nitrites and Nitrates: Other Considerations |
|
Definition
- Tolerance can develop if there is a sustained high plasma nitrate concentration
To prevent nitrate tolerance, skin patch should be removed for at least 12-14hrs each day |
|
|
Term
Organic Nitrites and Nitrates: Indications |
|
Definition
- Angina (all)
- Congestive Heart Failure (nitroglycerin, isosorbide dinitrate)
- Non-ST-Segment-Elevation Myocardial Infarction
- Acute Myocardial Infarction
|
|
|
Term
Ca2+ Channel Blockers: MOA |
|
Definition
- Artery dilation: results in reduced resistance to ventricular emptying (afterload), decreased cardiac work, reduced myocardial O2 demand (requires higher concentrations), little effect on most venous beds
- Actions in cardiac cells: verapamil and diltiazem depress the rate of SA node pacemaker and slow AV conduction
- Increase coronary blood flow: nifedipine, verapamil, diltiazem
|
|
|
Term
Ca2+ Channel Blockers: Adverse Effects |
|
Definition
- DHP: dizziness, hypotension, headache, flushing, nausea
- Nifedipine (immediate-releasing formula): worsening of angina due to coronary steal and/or reflex tachycardia
- Verapamil and Diltiazem: bradycardia, transient asystole
|
|
|
Term
Ca2+ Channel Blockers: Drug Interactions |
|
Definition
- Verapamil and a Beta Blocker can cause AV block and/or severe depression of ventricular function
- The use of verapamil to treat digitalis toxicity is contraindicated; AV nodal conduction disturbances may be exacerbated
|
|
|
Term
Fatty Acid Oxidation Inhibitor: MOA |
|
Definition
- Thought to block the trans-cellular late Na+ current --> by altering [Na+]i level, ranolazine blocks Na+ dependent Ca2+ channels, thus preventing Ca2+ overload
- Does not significantly alter HR or BP
- Used in combination with other antianginal drugs
- Decrease angina episodes and increase exercise tolerance
|
|
|
Term
Fatty Acid Oxidation Inhibitor: Adverse Effects |
|
Definition
- Known to increase the QT interval on the EKG
- Dizziness
- Headache
- Constipation
- Nausea/vomiting
|
|
|
Term
Fatty Acid Oxidation Inhibitor: Drug Interactions |
|
Definition
- CYP3A Inhibitors: diltiazem, verapamil, grapefuit juice
- Inhibitors of P-glycoprotein: amiodarone, clarithromycin, cyclosporin
- Risk of additive QT prolongation: quinidine (class Ia), dofetilide, sotalol, amiodarone (class III)
|
|
|
Term
Fatty Acid Oxidation Inhibitor: Indications |
|
Definition
- Chronic Stable Angina refractory to other antianginal drugs
- Acute coronary syndrome: Unstable Angina, NSTEMI
|
|
|